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Abstract
Purpose There is little information about the nutritional
status of cancer outpatients because the practice of
nutritional screening is rarely performed. This study
aims to define the pattern of scores of nutritional risk
in 1,453 outpatients and factors associated with a high
nutrition risk score, to facilitate the identification of
such patients by the oncologists.
Methods We prospectively screened the nutritional status of
cancer outpatients according to the NRS-2002 score which
combines indicators of malnutrition and of severity of the
disease (1–3 points, respectively). A score ≥3 indicates
“nutritional risk”. The association of the nutritional scores
with some patient/tumour/therapy-related variables was
investigated through univariable and multivariable linear
regression models.
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Results Thirty-two percent of outpatients were at nutritional
risk. Primary tumour site, Eastern Cooperative Oncology
Group score and presence of anorexia or fatigue were signif-
icantly associated with the nutrition risk score. Depending on
the combination of these variables, it was possible to estimate
different probabilities of nutritional risk.
Conclusions The frequency of a relevant nutritional risk
was higher than expected considering the favourably selected
population. The nutritional risk was associated with common
clinical variables which are usually recorded in the charts and
could easily alert the oncologist on the need of a further
nutritional assessment or a nutritional support.
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Introduction
The European Society for Clinical Nutrition and Metabo-
lism (ESPEN) defines nutrition risk [1] as “chances of a
better or worse outcome from disease or surgery according
to actual or potential nutritional and metabolic status” and
nutritional screening [2] as a “rapid and simple process
conducted by admitting staff or community healthcare
teams”. The importance of the nutritional screening cannot
be overlooked: the lack of routine screening procedure was
shown to leave over half the patients who are nutritionally at
risk unrecognised [3, 4] and one fourth without nutritional
support or counselling despite the presence of an active
contact of the patients with health care professionals [5].
Brown and Radke [6] in the USA and, more recently,
Hulmann and Cunningham [7] in UK have emphasized the
specific relevance of the nutritional screening also in the
treatment of weight loss in cancer patients.
The Nutritional Risk Screening (NRS 2002) is a tool
developed by Kondrup and an ESPEN working group in
2002 [2] with the assumption that the indications for nutrition
support are severity of undernutrition and increase in nutrition
requirements resulting from disease. It was designed to
include measures of both current potential undernutrition
and disease severity. It was validated against 128 controlled
nutrition support trials to evaluate whether it was capable to
distinguish those patients with a positive clinical outcome due
to nutrition intervention from those that showed no benefit of
nutrition support. Subsequently, a prospective, controlled trial
with 212 hospitalised patients using the NRS 2002 [8] showed
an increase in nutrition intake in patients who received nutri-
tion intervention because they were defined at nutritional risk
and a shorter length of hospital stay in those with complica-
tions (usually infections) who received a nutrition intervention
comparing with those without nutritional support. Since its
introduction in clinical practice, NRS 2002 (briefly NRS) was
used to screen the nutritional risk of a mixed patients’ popu-
lation and little attention was paid to the oncologic area and
among them the outpatients.
However, since cancer patients represent the commonest
segment of subject candidate to aggressive therapies both in
the hospital and in ambulatory setting, they might present a
state of malnutrition which can reduce the compliance to the
oncologic therapies and can be also worsened by such treat-
ments, this investigation focuses on screening the nutritional
risk of a large population of cancer outpatients. The present
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study represents the final step of multicenter prospective
protocol followed by the SCRINIO Working Group and
aiming to define the pattern of scores of nutritional risk
in a population of cancer outpatients, and to analyze the
factors associated with a high nutrition risk score. In the
perspective these data could help the clinician to iden-
tify patients at nutritional risk and hence to plan a
nutritional intervention.
Patients and methods
In 2003, during a scientific meeting in Milan, which
involved both oncologists and nutritionists, it was clear-
ly appreciated that there was a substantial discrepancy
of view between these specialists as regard the impact
that malnutrition might have on the outcome of the
cancer patient and the potential role of the nutritional
support. As a consequence, an open working group was
constituted with the aim of steering a protocol to prospectively
screen the nutritional status of the oncologic outpatients
(hence the acronym SCRINIO, that is SCReenIng the
Nutritional status In Oncology).
The endpoints of the study were: (1) to define prev-
alence and rate of malnutrition and of nutritional risk in
cancer outpatients and the need for a nutritional inter-
vention and (2) to investigate the association of some
patient-related, tumour-related and therapy-related varia-
bles with the nutritional risk. The eligibility criteria
included adult cancer outpatients presenting for diagnosis or
therapy or follow-up to the oncologic units of different
hospitals, university or scientific Institutions. Patients
were excluded from the study if they were affected by
endocrine diseases or they showed a severe impairment
of vital organs’ function.
The protocol collected some demographic data (age
and sex) of the patients, oncologic data [site of primary
tumour, histology, stage (defined according to the UICC
classification), Eastern Cooperative Oncology Group
(ECOG) performance state, oncologic therapy] and nutritional
data, namely the percentage of the weight loss at different
interval times before and during the illness and the body mass
index (BMI). Systemic and digestive symptoms as fatigue,
anorexia, nausea/vomiting, early satiety, dysgeusia/dysosmia,
odynophagia/dysphagia and diarrhoea/constipation were
classified semiquantitatively through a four-point score
(no, mild, moderate, severe).
Finally, the risk of complications related to malnutrition
was assessed through the NRS. Briefly, if the patients at the
initial screening have a BMI <20.5 Kg/m2 or they have lost
weight in the last 3 months or they have a reduced dietary
intake in the last week or they are severely ill, then they
move to the final screening where a quantification of the
previous parameters is completed and it summed with the
severity of the disease. The final scoring ranges from 0 to 6,
being 00no risk, 1–20 low risk, 3–40medium risk and >50
high risk (see Appendix 1). For age ≥70 years one addi-
tional score is added. A score ≥3 (we define it as “high
NRS score”) is considered worth requiring a further
deeper nutritional assessment for a potential nutritional
intervention, whereas for a lower score a periodic nutri-
tional surveillance is usually advised. This tool has been
demonstrated to have a high predictive validity and a low
interobserver variation (k00.76).
The study was implemented in 2004, included clinicians
of 20 (mainly Italian) centres (see Acknowledgments) and
closed to accrual on December 2008 after inclusion of 1,556
cancer patients. Of these, 103 lacked NRS information and
were thus excluded from analyses. Each centre got the
approval for the study and the informed consent form by
its own local ethics committee. The central study database
was held at the Fondazione IRCCS Istituto Nazionale
Tumori of Milan where data collected on each patient were
entered, checked for quality and completeness and elaborat-
ed. Details on the study protocol and preliminary results on
the first 1,000 patients have been recently published [9], and
database was previously utilized for two publications, one
on weight loss and its association with digestive and sys-
temic symptoms [10] and one on a definition and classifi-
cation of cancer cachexia [11].
Statistical methods
Descriptive analyses were based on standard statistics
such as relative frequencies for categorical variables
(gender, high NRS score, site of primary, UICC stage,
ECOG performance status, therapy and symptoms
degree) or otherwise with medians and interquartile
ranges (NRS score, age). We considered anorexia in
two different ways: “anorexia” as such, which simply
means lack of appetite, and “anorexia syndrome”, also
including symptoms interfering with food intake like
early satiety, taste or smell alterations, nausea/vomiting
and dysphagia/odynophagia [12]. The syndrome degree
was defined as the maximum degree recorded for each
of the contributing symptoms.
The patterns of association between NRS score and
age, gender, site of primary, UICC stage, ECOG PS,
therapy and symptoms were investigated by means of
univariable and multivariable linear regression models.
NRS score was alternatively treated as a continuous variable,
or as categorical toward a classification threshold of 3 (NRS
<3, NRS ≥3), denoting nutritional risk. Two-sided P values
below 0.05 were considered significant. We used SAS™ and
R software for computation.
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Results
Main series characteristics for the 1,453 patients with NRS
score information, as shown in Table 1, were in general as
expected for outpatients seen in the units of medical oncol-
ogy, with a prevalence of advanced disease stage (III or IV
according to the UICC classification, 80% of cases), good
performance status (0 or 1 on the ECOG scale, 80% of
cases) and some kind of oncologic treatment ongoing or
completed (70% and 16% of cases, respectively). Symp-
toms were relatively common, but severe in only a
minority of patients. As regards nutritional status, 32%
of the patients were defined at nutritional risk that is
14% were with an NRS score >3, and another 18%
were considered worthy of further nutritional assessment
because of an NRS score03.
Table 2 reports mean NRS score and percentage of
patients with high NRS score according to distinct patients’
characteristics. In both cases, significant results were always
achieved at the univariable and multivariable analyses, with
tumour stage and therapy being the only exceptions. In
particular, these two factors were no longer significant in
the multivariable analysis of the percentage of patients with
nutritional risk. Age (not shown) always failed to yield
significant results.
Table 3 shows the frequency estimated by the multivar-
iable analysis according to tumour site, ECOG performance
status and the presence of symptoms (anorexia and fatigue).
As regards the remaining two variables, which failed to
reach statistical significance in the multivariable analysis,
we arbitrarily assumed tumour stage 3 and no therapy
administration as reference categories to perform the calcu-
lation. Notably, the figures were obtained incorporating a
statistically significant synergistic effect of anorexia and
fatigue; namely, the joint presence of both symptoms was
shown to have an impact on the frequency of patients at
nutritional risk exceeding that expected by summation of
their distinct contributions.
It is possible to observe that the frequency of patients
with high NRS, 31.8% overall, was highly variable, ranging
between a minimum of 7.9% to a maximum of 97.6%. To
summarize, we found that conditions exceeding a 50%
frequency threshold were ECOG performance status ≥2
(20.1% of the series), or ECOG performance status01 in
the presence of both anorexia and fatigue (20.4% of the
series); frequencies were generally much lower and below
the 50% threshold in the remaining cases, with some detri-
mental effect of upper GI tumours compared to other tumour
sites. For instance, an upper GI patient has an 85.6% proba-
bility of high NRS score if ECOG PS03–4; the probability is
still high (83.5%) when ECOG PS01 but both symptoms are
present, whereas the probability drops to 15.4% when ECOG
PS00 and the patient is asymptomatic.








Age (years)a, median (IQ range) 64.0 (55–71)
Site of primary tumour




Small bowel 33 2.3
Colon–rectum 518 35.7
Lung 217 15.0


















Never treated 203 14.0
Past treated 234 16.1
Ongoing, one 838 57.7
Ongoing, two 164 11.3









Median (IQ range) 2 (0–3)
Anorexia symptom
No 683 47.2
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Discussion
This study represents the first investigation using systemat-
ically the NRS 2002 to define the nutritional risk of cancer
outpatients despite the guidelines by the American Society
of Parenteral and Enteral Nutrition [13] that all patients
should undergo nutritional screening dating back to 2002.
These recommendations have been quite recently replicated
in ad hoc ASPEN guidelines [14] and by the National
Cancer Institute [15]. However, a recent survey in UK [16]
showed that 80% of specialist oncological trainees expressed
uncertainty or a lack of confidence in their ability to identify
malnutrition and a similar study in US radiology oncologists
[17] reported that only 9% of them used body weight plus
other assessment tools.
Although several screening tools are available, there is no
consensus among the experts upon the best way of screening
the nutritional status of cancer patients and several of these
tools, including the malnutrition screening tool [18–20], the
malnutrition universal screening tool [21] and the patient-
generated subjective global assessment [21–25], the
subjective global assessment [21, 23, 26, 27] and the nutrition
risk index [27, 28] are validated in oncology patients.
A large comparative study has shown that NRS 2002 has
a better performance than the malnutrition universal screen-
ing tool and the nutrition risk index, compared to subjective
global assessment [29]. Similarly, attempts to validate the
malnutrition universal screening tool in a population with
cancer showed that it was unsuitable for use because of low
sensitivity and specificity [21, 30].
On the contrary, Sorensen et al. [31] have shown that the
nutritional status determined by NRS 2002 maintained a
significant independent association with complications even
when adjusted for possible confounders as presence of cancer.
We found that NRS 2002 is fully suitable for cancer
population since many recognized prognostic factors
(type of primary tumour, performance status, symptoms)
parallel with the score of the NRS 2002.
The most striking finding of this study was that one third
of our patients were considered with a high NRS, a percent-
age somewhat lower than the value (49%) recently reported
by Isenring et al. [32] on a mixed population of 191 inpa-
tients and outpatients. Our figure is intermediate between
the values extrapolated for hospitalised cancer patients from
large surveys of mixed pathologies populations, which range
from 27% to 43% [20, 31, 33–35], while in advanced cancer
patients enrolled in palliative home care services, the
nutritional risk may rise till 68% [36]. Such a percentage
of nutritionally at risk outpatients is especially remarkable and
worrisome when considering that patients able to attend an
ambulatory consultation or therapy should represent a favour-
ably selected segment of the cancer population.
Since a score of 3 calls for a further more exhaustive
nutritional assessment, it is noteworthy that a median value
of 3 was observed in patients with cancer of the oesophagus
and pancreas, in those with ECOG score ≥2 and in those
with anorexia or fatigue of degree classified as moderate or
severe. All of these factors achieved statistical significance
also at the multivariable analysis (Table 2).
Even if oncologists do not feel comfortable, confident or
adequately prepared to provide nutrition counselling, such a
remarkable prevalence of outpatients with high nutritional risk
should alert them to face actively with this issue for two
reasons. First, the deleterious effects of malnutrition on
compliance with oncologic therapies [37, 38] and response to
treatment [39–45] are well recognized, and secondly, there is a
growing experience that an early nutritional intervention
when tumour burden is still limited is able to achieve a
clinical benefit [46–48].
Finally, although undernutrition cannot entirely explain the
progressive deterioration of the general status of the cancer
patients, nevertheless, the correlation between NRS score and
anorexia (which accounts for 76% of the NRS score ≥3) is in

























N.R. not reported, IQ interquartile, UICC International Union Against
Cancer, ECOG PS Eastern Cooperative Oncology Group performance
status
aMissing data in ten cases
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the weight loss in the early stage of disease as shown in
metabolic investigations [49, 50] and in RCTs [46–48].
Recently, Odelli et al. [51] reported that when applying a
periodic nutrition assessment of all oesophageal cancer patient
Table 2 Mean NRS score and
percentage of patients with
nutritional risk (NRS score ≥3),
according to main patients’
characteristics
aP value from the univariable
analysis
bP value from the multivariable
analysis
cNot included in the multivari-
able analysis




Oral cavity 116 1.5 28.5
Oesophagus 80 3.1 62.5
Stomach 206 2.3 43.7
Pancreas 90 2.6 <0.0001a 54.3 <0.0001a
Small bowel 33 1.1 <0.0001b 6.1 0.0002b
Colon–rectum 518 1.5 24.3
Lung 217 1.7 28.1
Upper respiratory airways 84 1.4 28.6
Other 107 1.4 25.2
Tumour stage
0 10 0.6 10.0
I 51 1.4 <0.0001a 19.6 <0.0001a
II 150 1.5 0.0308b 23.3 0.1333b
III 298 1.8 33.2
IV 578 1.7 29.8
ECOG PS
0 514 0.9 10.1
1 426 2.0 <0.0001a 35.5 <0.0001a
2 185 3.3 <0.0001b 79.5 <0.0001b
3 47 4.0 91.5
4 4 5.0 100.0
Therapy
Never treated 203 1.6 29.6
Past treated 234 2.1 0.0017a 40.6 0.0052a
Ongoing, one 838 1.7 0.0742b 28.8 0.0669b
Ongoing, two 164 1.9 37.2
Ongoing, three 14 2.1 35.7
Anorexia
No 683 1.0 <0.0001a 11.0 <0.0001a
Mild 362 2.0 <0.0001b 36.5 <0.0001b
Moderate 304 2.7 57.9
Severe 97 3.5 79.4
Anorexia syndrome
No 349 0.8 <0.0001a 6.0 <0.0001a,c
Mild 401 1.5 22.0
Moderate 477 2.2 41.5
Severe 224 3.0 69.2
Fatigue
No 455 0.9 <0.0001b 11.4 <0.0001a
Mild 536 1.7 <0.0001a 23.5 <0.0001b
Moderate 359 2.6 58.2
Severe 99 3.4 75.8
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candidates to chemoradiation, they were able to identify
patients at risk for malnutrition, to start early with nutritional
support and to achieve a clinical benefit (less weight loss,
greater radiotherapy completion, fewer and shorter unplanned
hospital admission) as compared with a historical group of
similar patients.
Furthermore Table 3 reports the probability for a
patient to fall in a high NRS depending on the different
combination of the site of primary tumour, presence or
absence of some symptoms and values of the ECOG
scale. It was not our intention to make a comparison
with other screening methods, however it is worthy of
note that these clinical variables together with some
information on weight change, anorexia, performance
status and gastrointestinal disturbances are commonly
collected during the clinical oncologic examination and
recorded in the chart. Moreover, body weight and height
(and hence the BMI) are necessary to calculate the body
area surface on which the doses of chemotherapeutics
are calculated. Hence the presence of such variables can
alert the clinician upon the potential onset of nutrition-
related problems. In such a way, the oncologist is able
to suspect any condition of nutritional risk and conse-
quently depending on the severity of the situation, can
provide the patient with some simple preventative suggestions
(i.e. anti-anorectic/anti-cachectic agents or nutritional
supplementations) or to defer him/her to a specialised
nutrition support team.
There are some points of weakness in the study. Despite
the high number of patients, this study does not involve all
types of tumour, and patients with urogenital, bone and soft
tissue malignancies are underrepresented. Hence our
results cannot be generalised to all cancer population.
It is true, however, that the variables we identified as
significant (namely deterioration of the performance status,
anorexia, fatigue) are expression of the metabolic component
and the severity of the disease rather than a marker of a
specific tumour and have a prognostic relevance in a
variety of tumours.
Furthermore, oncologic treatments were disparate as
regards type, administration and time interval from
examination/interview of the patients, and we cannot
exclude that some particularly aggressive therapies may
adversely affect the nutritional risk. In such cases,
however, the oncologist is usually aware of the impact
of the oncologic treatment on the nutritional status and
hence more than a screening procedure, a strict active
surveillance of the occurrence of the potential nutri-
tional complications is required.
In conclusion, this study shows that a large popula-
tion of cancer outpatients, about one third, presents a
high nutritional risk. Even though oncologists may be
unfamiliar with nutritional tools or nutritional risk
scores, nevertheless, the determination of some simple
factors as site of primary tumour, the performance status
and the presence of some symptoms (anorexia and fatigue)
may alert them about a condition of nutritional deterio-
ration of their patients and the potential use of a nutritional
support.
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